Table 1.
Characteristics of study population by diagnostic group.
Figure 1.
Heparanase levels in the urine and blood of study subjects.
Determination of heparanase levels in urine (A, B) and plasma (C, D) of individuals from the study groups. Shown are average (±SE; A, C) and median (B, D) values quantified by an ELISA method, as described under ‘Materials and Methods’.
Table 2.
Association between log transformed urine heparanase/creatinine levels and studied parameters in transplanted (n = 100) and CKD (n = 41) patientsa.
Figure 2.
Urine heparanase levels inversely associate with eGFR in kidney transplanted patients.
Heparanase/creatinine levels are plotted in relation to eGFR values. Note significant inverse association of urine heparanase with eGFR (p = 0.035, r = −0.2224) (Spearman nonparametric correlation test).
Figure 3.
Log transformed urinary heparanase/creatinine and log transformed urinary protein/creatinine.